Literature DB >> 4020141

Schistosoma mansoni: detection by monoclonal antibody of a 22,000-dalton surface membrane antigen which may be blocked by host molecules on lung stage parasites.

D A Harn, M Mitsuyama, E D Huguenel, J R David.   

Abstract

Monoclonal antibody M.2 binds to the surface membranes of cercariae and developing schistosomula. This antibody was generated from mice immunized with membrane-enriched extracts of mechanically transformed schistosomula. The antigen detected by M.2 was shown to persist on developing schistosomula for at least 96 hr post-transformation. M.2 also bound to the surface of living, cultured lung worms but not to freshly harvested lung worms. The ability of M.2 to bind to cultured lung worms coincided with the loss of host H-2 from the parasite surface. The apparent m.w. of the antigen was 22,000; an antigen with the same apparent m.w. was immunoprecipitated from cercariae, schistosomula, lung worms, and adult worms.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4020141

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  7 in total

1.  Human immune responses to Schistosoma mansoni vaccine candidate antigens.

Authors:  A Ribeiro de Jesus; I Araújo; O Bacellar; A Magalhães; E Pearce; D Harn; M Strand; E M Carvalho
Journal:  Infect Immun       Date:  2000-05       Impact factor: 3.441

Review 2.  Schistosome vaccines.

Authors:  D W Taylor
Journal:  Experientia       Date:  1991-02-15

3.  DNA-based vaccines protect against zoonotic schistosomiasis in water buffalo.

Authors:  Akram A Da'dara; Yuesheng S Li; Tie Xiong; Jie Zhou; Gail M Williams; Donald P McManus; Zheng Feng; Xin L Yu; Darren J Gray; Donald A Harn
Journal:  Vaccine       Date:  2008-05-19       Impact factor: 3.641

4.  Candidate vaccine antigens identified by antibodies from mice vaccinated with 15- or 50-kilorad-irradiated cercariae of Schistosoma mansoni.

Authors:  D Richter; D A Harn
Journal:  Infect Immun       Date:  1993-01       Impact factor: 3.441

5.  Mapping the binding between the tetraspanin molecule (Sjc23) of Schistosoma japonicum and human non-immune IgG.

Authors:  Chuang Wu; Pengfei Cai; Qiaocheng Chang; Lili Hao; Shuai Peng; Xiaojing Sun; Huijun Lu; Jigang Yin; Ning Jiang; Qijun Chen
Journal:  PLoS One       Date:  2011-04-20       Impact factor: 3.240

6.  A pilot study on developing mucosal vaccine against alveolar echinococcosis (AE) using recombinant tetraspanin 3: Vaccine efficacy and immunology.

Authors:  Zhisheng Dang; Kinpei Yagi; Yuzaburo Oku; Hirokazu Kouguchi; Kiichi Kajino; Jun Matsumoto; Ryo Nakao; Hiroyuki Wakaguri; Atsushi Toyoda; Hong Yin; Chihiro Sugimoto
Journal:  PLoS Negl Trop Dis       Date:  2012-03-27

Review 7.  Novel therapeutic and prevention approaches for schistosomiasis: review.

Authors:  Rashika A F El Ridi; Hatem A-M Tallima
Journal:  J Adv Res       Date:  2012-06-23       Impact factor: 10.479

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.